Tuberculosis is one of the oldest disease known to affect human, is a major leading cause of death in developing countries. Immunity plays very important role next to causative organism mycobacterium tuberculi as mycobacterium tuberculi mostly affect the person with low immunity. In Ayurveda tuberculosis is considered as Rajayakshma or kshaya which leads to dhatu kshaya due to obstruction of Srotas.Rasayana drugs improve the quality of Rasa Dhatu so good quality of Rakta Mamsa Meda Asthi Majja Shukra and Ojus is formed, so excellence of all Dhatus is achieved. It also improve the microcirculation hense improves tissue nourishment. So Ashwagandha which is extensively used in Ayurveda as Rasayana is selected in pulmonary tuberculosis as adjuvant therapy.
The present study aims to evaluate the effect of Phalatrikādi kwātha in the management of KoshthaśākhāśritaKāmalā (hepatocellular jaundice) on the basis of various clinical and laboratorial parameters.
The clinical manifestations of Koshthaśākhāśrita Kāmalā are very much similar to that of hepatocellular jaundice. There are several causes of hepatocellular jaundice but viral hepatitis, alcoholic liver disease, drug-induced hepatitis are the common among them.
The trial drug Phalatrikādi Kwātha, consisting of eight herbal drugs (āmalakī, harītakī, vibhītaka, guduci, kutakī, nimba, kirātatikta and vāsā) is a very useful preparation indicated by Śārangdhara for the management of Kāmalā Roga.
All the 50 registered patients were assessed on clinical and laboratorial parameters to evaluate the effect of Phalatrikādi kwātha in the management of Koshthaśākhāśrita Kāmalā. Initially there was slow but steady clinical recovery but later on patients showed very fast recovery in clinical symptoms. Significant reduction in serum bilirubin, S.G.O.T, S.G.P.T, ALP and significant increase in Hb%, total serum protein, serum albumin justifies the curative effect of phalatrikādi kwātha in Koshthaśākhāśrita Kāmalā.
Musculoskeletal disorders are the common cause of disability in world. Further, among these disorders Sandhigata Vata (osteoarthritis) is the most common joint disorder. In allopathic system of medicine, the management mainly based on symptomatically relief of painful conditions, but still there is need for such therapeutic regimen that could retard the disease progression. Until now, no such regimen is present. For the search of such agents, Herbal remedies and dietary supplements have become an important area of research and clinical practice in orthopedics and rheumatology. In Ayurveda, Sandhigata Vata described under Vata Vyadhi. This disease occurs by vitiation of Vata Dosha. Symptomatically Sandhigata Vata is much close to osteoarthritis (OA). This review framed to discuss the recent advancement in use of Ayurvedic drugs for management of osteoarthritis. Several Ayurvedic drugs used by physicians to treat osteoarthritis demonstrated significant biological and immunological effects in clinical drug trials, hence providing a new platform for development of new effective treatment regimens and better patient care. Main aim of this review article is to find out such evidence-based medicine so that we can have a way for further studies
Not divergently but unified only prevalent pathies of medicine viz. allopathy, Ayurveda, unani, siddha, sowa-rigpa etc. can effectively meet the challenges which we face today in our healthcare delivery system in the country by making the system more accessible and affordable. From human resources shortage to low cost infrastructure and medicines, given less government spending, we can make it through mainstreaming of the traditional systems of Medicine by totally incorporating them into modern medicine or vice versa. And that could be possible through empowering Indian System of Medicine doctors legally by giving them all rights and opportunities which are available to allopathic doctors in the country in addition to their relevant teaching and training. This would be done by bringing legislative amendments in pertaining Acts and laws of the land; which could be a part of plan to step up mainstreaming. And for that the MTP Act, PC & PNDT Act, Factory Act, Indian Medical Degrees Act, Insurance and Reimbursement Act, CCIM Act of 1970 and MCI Act all need central legislative amendments. This would also facilitate research and development in ISM by resolving certain outstanding ethical issues. Here a review has been made on the basis of literature with an objective of optimal utilisation of ISM doctors to strengthen the public health care delivery system and to meet various challenges. This needs kind attention of Ministers, political leaders, policymakers and bureaucrats.
KEYWORDS: Healthcare challenges, Traditional Indian Systems of Medicine, Mainstreaming, Central Acts and Amendments.
Yastimadhu (Glycyrrhiza glabra Linn) is an herbal material used in different compound formulations as well as single for treating various disease conditions. In the current study the used parts of Yastimadhu i.e. root is assessed for its pharmacognostical and Phyto-chemical findings. In the pharmacognostical study, the sample material is evaluated for both morphologically and microscopically, and observed for peculiar secondary growth in Yastimadhu (Glycyrrhiza glabra Linn) root with centrally present pith pigments, alternative bands of xylem and phloem, combined with medullary rays. These could be the finger print for the particular test sample. In Phyto-chemical study the presence of different organic materials like carbohydrate, proteins, tannins, glycosides, phenols are found whereas test for alkaloid presence is found negative. The data obtained are discussed critically to lay out the possible way of raw drug standardization for herbal material. Hope this scientific write up will be a step ahead for drug standardization in Ayurvedic system of treatment.